CCDC15 Inhibitors
CCDC15 inhibitors encompass a diverse group of compounds that indirectly affect CCDC15 through their action on various cellular pathways. These inhibitors do not target CCDC15 directly, but rather modulate the cellular environment in a way that leads to diminished CCDC15 activity. Rapamycin, for instance, disrupts mTORC1 signaling, a pathway that is integral to the process of ciliogenesis. As CCDC15 is associated with ciliogenesis, the inhibitory effect of rapamycin on mTORC1 would result in a reduced capacity for cells to form and maintain cilia, thereby indirectly reducing the functionality of CCDC15, which is presumed to play a role in this process. Other compounds such as LY294002 and 3-Methyladenine inhibit PI3K, which is upstream of several signaling pathways, including those that may regulate CCDC15's activity or expression.
The diversity of these inhibitors highlights the complexity of cellular signaling networks and the multiple points at which intervention can lead to changes in specific protein functions. Modulation of CCDC15 activity may be beneficial for research purposes, to dissect the biological pathways in which CCDC15 participates. Understanding the precise mechanisms by which these compounds affect CCDC15 and related pathways can provide deeper insights into cellular processes such as ciliogenesis, autophagy, and cell cycle regulation, which are critical to cellular homeostasis and disease states.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that blocks the mTORC1 complex, which is crucial for protein synthesis and cell growth. Inhibition of mTORC1 can lead to reduced ciliogenesis, a process in which CCDC15 is involved, thereby indirectly inhibiting CCDC15 function by limiting the formation of cilia where it operates. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that halts the PI3K/Akt pathway, leading to decreased phosphorylation and activation of downstream targets. Given that CCDC15 is implicated in signaling pathways regulated by PI3K/Akt, inhibition by LY294002 can decrease the functional activity of CCDC15 by dampening the signals that facilitate its cellular roles. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase (V-ATPase). By preventing the acidification of organelles, it hampers autophagosome-lysosome fusion, which is vital for autophagy. CCDC15 is associated with autophagosome function, and its activity can be indirectly inhibited due to disruption of autophagy. | ||||||
rac Perhexiline Maleate | 6724-53-4 | sc-460183 | 10 mg | $188.00 | ||
Perhexiline inhibits mitochondrial carnitine palmitoyltransferase-1 (CPT1), which alters fatty acid metabolism and energy production. By affecting energy-dependent processes such as ciliogenesis, perhexiline indirectly inhibits CCDC15's role in these processes due to energy deprivation. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is an agent that disrupts microtubule polymerization. By interfering with microtubule dynamics, nocodazole can inhibit CCDC15 function as it may be implicated in microtubule-based processes such as ciliogenesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to inhibit autophagy by preventing the acidification of lysosomes and autophagosome fusion. Since CCDC15 is linked with autophagosome function, its activity is indirectly inhibited due to the prevention of autophagy completion. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly. This can lead to defective microtubule dynamics, which can indirectly inhibit CCDC15 by disrupting processes such as ciliogenesis in which proper microtubule function is essential. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C is a DNA crosslinker that halts the cell cycle. Since the initiation of ciliogenesis is coordinated with cell cycle progression, mitomycin C can indirectly inhibit CCDC15 by arresting the cell cycle and thereby preventing ciliogenesis. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a CDK inhibitor that leads to cell cycle arrest. As CCDC15 is involved in ciliogenesis, which is linked to the cell cycle, roscovitine can indirectly inhibit CCDC15 by disrupting the timing of ciliogenesis. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is a PI3K inhibitor that primarily interferes with the initiation of autophagy. By inhibiting the early stages of autophagy, this compound indirectly inhibits CCDC15, presuming its involvement in autophagosome formation or function. | ||||||